Neuroregenerative Effects of Radio Electric Asymmetric Conveyer (REAC) Neuroregenerative (RGN-N) Therapy in Pediatric Adrenoleukodystrophy: A Case Report

This case report presents the use of radio electric asymmetric conveyer (REAC) neuroregenerative (RGN-N) therapy in a pediatric patient with adrenoleukodystrophy (ALD), a progressive neurodegenerative disorder with limited therapeutic options. The patient underwent three REAC RGN-N treatment cycles, each lasting 72 hours, with approximately 6-7 hours of daily sessions. An asymmetric conveyor probe (ACP) was positioned along the spine to channel the interaction of the emitted radio electric field with cellular electro-metabolic alterations, promoting progressive bioelectrical restoration. The treatment parameters were pre-set on the REAC device (BENE 110, ASMED, Scandicci, Italy) and could not be altered by the operator, ensuring consistent therapeutic delivery. Significant functional improvements were observed across the motor, cognitive, and swallowing domains, as assessed by standardized scales. This report aligns with preclinical studies on REAC technology's potential for neuroregeneration and suggests REAC RGN-N therapy as a promising adjunctive intervention in ALD management.